期刊文献+

高危前列腺癌以根治手术为核心的治疗策略

下载PDF
导出
摘要 高危前列腺癌最常用的定义由D'Amico提出,即临床分期≥T2c,或Gleason评分8~10分,或前列腺特异抗原(PSA)≥20ng/mL,但是新近认为T2c的患者应该被归人中危组。最新版《中国泌尿外科疾病诊断治疗指南》,2009年欧洲泌尿外科学会和美国国立癌症综合网络(NCCN)的关于局限性前列腺癌的诊治指南中,把临床分期T3a,或Gleason评分8~10分,或PSA≥20ng/mL定义为高危前列腺癌。由于缺乏PSA筛查,国内局限性前列腺癌患者大部分属于高危。
出处 《老年医学与保健》 CAS 2010年第4期198-201,共4页 Geriatrics & Health Care
  • 相关文献

参考文献24

  • 1D'Amico VA, Whittington R, Malkowicz BS, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer [J]. Jama, 1998, 280 (11): 969-974.
  • 2Cooperberg RM, CowanJ, Broering MJ, et al. High-risk prostate cancer in the United States, 1990-2007 [J]. World J Urol, 2008, 26 (3): 211-218.
  • 3Peyromaure M, Debre B, Mao K, et al. Management of prostate cancer in China: a multicenter report of 6 institutions [J]. J Urol, 2005, 174 (5): 1794-1797.
  • 4Yossepowitch O, Eggener ES, Bianco JF, et al. Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods [J]. J Urol, 2007, 178 (2): 493-499; discussion 499.
  • 5Ward FJ, Slezak MJ, Blute LM, et al. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome [J]. BJU Int, 2005, 95 (6): 751-756.
  • 6Carver SB, Bianco JF Jr, Scardino TP, et al. Long-term outcome following radical prostatectomy m men with clinical stage T3 prostate cancer [J]. J Urol, 2006, 176 (2): 564-568.
  • 7Freedland JS, Partin WA, Humphreys BE, et al. Radical prostatectomy for clinical stage T3a disease [J]. Cancer, 2007, 109 (7): 1273-1278.
  • 8Bastian JP, Gonzalgo LM, Aronson JW, et al. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10 [J]. Cancer, 2006,107 (6): 1265-1272.
  • 9Magheli A, Rais-Bahrami S, Peck JH, et al. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy [J]. J Urol, 2007, 178 (4 Pt 1): 1311-1315.
  • 10Berglund KR, Jones SJ, Ulchaker CJ, et al. Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: a prospective analysis [J]. Urology, 2006, 67 (6): 1253-1256.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部